In a significant move within the sphere of global public affairs, Mark T. Elliot has been appointed as the new Senior Director at Crowell & Moring International LLC (CMI). Elliot, a seasoned veteran with over thirty years of experience in strategic public affairs, communications, government affairs, and trade policy, is set to bring his extensive expertise to CMI, a leading public policy and public affairs firm based in Washington, D.C.

Elliot’s career is distinguished by his proficiency in shaping policy environments across a variety of sectors including healthcare, pharmaceuticals, intellectual property, and international trade. His role at CMI will focus on providing strategic support to clients, helping them navigate and influence international policy, and addressing complex challenges at the intersection of corporate, government, and political landscapes. His collaboration with Crowell & Moring’s legal teams, particularly in the International Trade and Health Care groups, promises to bolster the firm’s offerings to its global clientele.

Before his latest appointment, Elliot held the position of Senior Vice President at Albright Stonebridge Group, a global business strategy firm. His achievements there were preceded by a critically acclaimed stint as Executive Vice President at the U.S. Chamber of Commerce. Here, he led the Global Innovation Policy Center, advocating for innovation and intellectual property rights as key drivers of the global economy. Additionally, Elliot’s professional journey includes nearly a decade at Pfizer, in various roles culminating as Senior Director of International Public Affairs and Policy.

His prowess isn’t confined to the corporate sector alone; Elliot has a noteworthy history in government service which includes over a decade spent in various capacities within the Australian government. He has also addressed national and international bodies, providing testimony before U.S. House and Senate Committees, the Office of the United States Trade Representative, and the International Trade Commission.

The leadership at CMI, including President and CEO Geralyn Ritter, holds high expectations for Elliot. Ritter noted that his global experience in heavily regulated industries will significantly enhance CMI’s service offerings. In an era marked by rapid technological advancements in healthcare, Elliot’s expertise is seen as crucial in helping entities manage change, finance progress, and ensure access to innovation.

Elliot himself expressed enthusiasm about his new role, noting his long-standing professional relationships with other key advocates at CMI, including Ritter and Joe Damond. He articulated a commitment to supporting and advancing the interests of CMI’s diverse global client base.

CMI, with operations in Washington, D.C., Singapore, and Hong Kong, is strategically positioned in key global markets. The firm is known for its sophisticated analysis and advisory services in government relations, public policy, and public affairs, leveraging a team comprised of former White House and Capitol Hill senior staffers, as well as veterans from various U.S. government agencies and international ministries.

This appointment signals CMI’s aim to deepen its engagement with global policy issues and reinforces its commitment to providing top-tier strategic advice to its clients worldwide. With experts like Mark T. Elliot at the helm, CMI is well-positioned to influence and shape the future of global public affairs.